Related references
Note: Only part of the references are listed.Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years
Hannah Stocker et al.
ALZHEIMERS & DEMENTIA (2023)
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
Gemma Salvado et al.
EMBO MOLECULAR MEDICINE (2023)
Astrocytic α2-Na+/K+ ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model
Carolyn N. Mann et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability
Joel Simren et al.
ALZHEIMERS & DEMENTIA (2022)
Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer's disease
Disha Shah et al.
CELL REPORTS (2022)
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial
Michael J. Pontecorvo et al.
JAMA NEUROLOGY (2022)
Causal links among amyloid, tau, and neurodegeneration
Murat Bilgel et al.
BRAIN COMMUNICATIONS (2022)
Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology
Tengfei Guo et al.
BIOLOGICAL PSYCHIATRY (2021)
Higher levels of the astrocytic marker CSF YKL40 are associated with better memory performance only in amyloid‐positive individuals with subjective cognitive decline
Gonzalo Sánchez‐Benavides et al.
Alzheimers & Dementia (2021)
Amyloid-β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease
Maria V. Sanchez-Mico et al.
GLIA (2021)
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease
Pratishtha Chatterjee et al.
TRANSLATIONAL PSYCHIATRY (2021)
Cerebral amyloid-β load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuum
Gemma Salvado et al.
ALZHEIMERS & DEMENTIA (2021)
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Andrea L. Benedet et al.
JAMA NEUROLOGY (2021)
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease
Joana B. Pereira et al.
BRAIN (2021)
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
Huiqin Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Harald Hampel et al.
FRONTIERS IN IMMUNOLOGY (2020)
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
Marta Mila-Aloma et al.
ALZHEIMERS & DEMENTIA (2020)
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers
Andrea Vergallo et al.
NEUROBIOLOGY OF AGING (2020)
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2020)
Consideration of Sex Differences in the Measurement and Interpretation of Alzheimer Disease-Related Biofluid-Based Biomarkers
Michelle M. Mielke
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation
Mithilesh Kumar Jha et al.
NEUROSCIENTIST (2019)
Astrocyte Heterogeneity: Impact to Brain Aging and Disease
Isadora Matias et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development
Filippo Baldacci et al.
EXPERT REVIEW OF PROTEOMICS (2019)
Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia
Clifford R. Jack et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Claire Bridel et al.
JAMA NEUROLOGY (2019)
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Sebastian Palmqvist et al.
EMBO MOLECULAR MEDICINE (2019)
Astrocyte Biomarkers in Alzheimer's Disease
Stephen F. Carter et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Isabelle Bos et al.
ALZHEIMERS & DEMENTIA (2019)
Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease
Angela Gomez-Arboledas et al.
GLIA (2018)
Deciphering the Astrocyte Reaction in Alzheimer's Disease
Beatriz G. Perez-Nievas et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Shorena Janelidze et al.
NEUROLOGY (2018)
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases
Filippo Baldacci et al.
EXPERT REVIEW OF PROTEOMICS (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease
Elena Rodriguez-Vieitez et al.
BRAIN (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD
Juan Domingo Gispert et al.
NEUROBIOLOGY OF AGING (2016)
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
William E. Klunk et al.
ALZHEIMERS & DEMENTIA (2015)
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
Daniel Alcolea et al.
NEUROLOGY (2015)
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
Luca Steardo et al.
FRONTIERS IN NEUROSCIENCE (2015)
Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
Priyanka Narayan et al.
BIOCHEMISTRY (2014)
Biobanking of CSF: International standardization to optimize biomarker development
Charlotte E. Teunissen et al.
CLINICAL BIOCHEMISTRY (2014)
The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline
Michael C. Donohue et al.
JAMA NEUROLOGY (2014)
lavaan: An R Package for Structural Equation Modeling
Yves Rosseel
JOURNAL OF STATISTICAL SOFTWARE (2012)
GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease
Willem Kamphuis et al.
PLOS ONE (2012)
Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer's Disease
Alberto Serrano-Pozo et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Concomitant Astroglial Atrophy and Astrogliosis in a Triple Transgenic Animal Model of Alzheimer's Disease
Markel Olabarria et al.
GLIA (2010)
Spanish Multicenter Normative Studies (NEURONORMA Project): Norms for the Rey-Osterrieth Complex Figure (Copy and Memory), and Free and Cued Selective Reminding Test
Jordi Pena-Casanova et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2009)
Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains
RG Nagele et al.
BRAIN RESEARCH (2003)
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
T Wyss-Coray et al.
NATURE MEDICINE (2003)
Share Paper
